AGO2 and breast carcinoma: Breast cancer cell lines (MDA-MB-231, MDA-MB-468 and SKBR3) and a normal breast cell line (MCF-10A) were used to validate the expression levels of the signature m7GRGs (AGO2, EIF4E3, DCPS and EIF4E).